This announcement is a separate document:
复星医药：及其发行的16复药01、17复药01、18复药01、18复药02与18复药03跟踪评级报告
Fosun Pharmaceuticals: Follow-up rating reports for 16 compounding drugs 01, 17 compounding drugs 01, 18 compounding drugs 01, 18 combos 02 and 18 combos 03
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.